Lasa Supergenerics Ltd vs Ortin Global Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Lasa Supergenerics Ltd is ₹ 7.96 as of 30 Apr 15:30 . The P/E Ratio of Lasa Supergenerics Ltd changed from 10.7 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Ortin Global Ltd changed from 27.8 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Lasa Supergenerics Ltd changed from ₹ 243.63 crore on March 2021 to ₹ 84.42 crore on March 2025 . This represents a CAGR of -19.10% over 5 yearsThe Market Cap of Ortin Global Ltd changed from ₹ 26.22 crore on March 2021 to ₹ 8.12 crore on March 2025 . This represents a CAGR of -20.90% over 5 years The revenue of Lasa Supergenerics Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 revenue of ₹ 3.07 crore. This represent the decline of -27.69% The revenue of Ortin Global Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 revenue of ₹ 0.01 crore. This represent the decline of 0% The ebitda of Lasa Supergenerics Ltd for the Dec '25 is ₹ -0.73 crore as compare to the Sep '25 ebitda of ₹ -3.99 crore. This represent the decline of -81.7% The ebitda of Ortin Global Ltd for the Dec '25 is ₹ -0.05 crore as compare to the Sep '25 ebitda of ₹ -0.5 crore. This represent the decline of -90% The net profit of Lasa Supergenerics Ltd changed from ₹ -2.73 crore to ₹ -2.55 crore over 7 quarters. This represents a CAGR of -3.82% The net profit of Ortin Global Ltd changed from ₹ -0.1 crore to ₹ -0.05 crore over 7 quarters. This represents a CAGR of -32.70% The Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Ortin Global Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016.
The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

About Ortin Global Ltd

Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind.
The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India.
The company is engaged in manufacture of Pharma formulations.
They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India.
The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations. The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers.

FAQs for the comparison of Lasa Supergenerics Ltd and Ortin Global Ltd

Which company has a larger market capitalization, Lasa Supergenerics Ltd or Ortin Global Ltd?

Market cap of Lasa Supergenerics Ltd is 39 Cr while Market cap of Ortin Global Ltd is 12 Cr

What are the key factors driving the stock performance of Lasa Supergenerics Ltd and Ortin Global Ltd?

The stock performance of Lasa Supergenerics Ltd and Ortin Global Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lasa Supergenerics Ltd and Ortin Global Ltd?

As of May 3, 2026, the Lasa Supergenerics Ltd stock price is INR ₹7.96. On the other hand, Ortin Global Ltd stock price is INR ₹15.5.

How do dividend payouts of Lasa Supergenerics Ltd and Ortin Global Ltd compare?

To compare the dividend payouts of Lasa Supergenerics Ltd and Ortin Global Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.